In this episode, we talk with Laura Towart, Founder & CEO of Vivian Therapeutics, a company that revolutionizes cancer treatment by personalizing it to each patient's unique tumor using an army of 500,000 fruit fly avatars. They use a patient's genes against all FDA-approved drugs to identify the drug combinations for people with advanced cancer. We also learn about their tool, TuMatch, which can quickly find treatments for colorectal cancer patients.

This week's guest is Dr. Sandip Patel, a professor of medical oncology from UC San Diego. Dr. Patel and Dr. Juneja talk about the gut microbiome, how it affects our health, and especially how it relates to cancer. In this very interesting episode, Dr. Patel shares some insights about his studies on bacteria that can impact cancer treatments. We also learn about antibiotics, probiotics, acid reflux, and the relationship between diet and cancer.

This episode's guest is "America's Favorite Doctor,” Dr. Laura Purdy, a board-certified Family Medicine Physician. Dr. Purdy joins Dr. Juneja to talk about telehealth and how it's changing patients' lives by increasing access to care. In this episode, we learn how to find a doctor from the comfort of our own home and how screenings and prescriptions work on these virtual healthcare visits. On the topic of cancer, Dr. Purdy also shares her perspective on genetic tests for cancer prevention.

Our guest this week is Mark Shapiro, COO of xCures. Dr. Sanjay and Mark talk about the importance of accessing and structuring patient medical records and how they can be used to help guide treatments and improve patient care. In this episode, learn about advancements in AI software that are now transforming the oncology sector and how xCures is harnessing this technology and making it available to every cancer patient and oncologist in the US.

Dr. Sanjay Juneja had the pleasure of talking with Dr. Pedro Barata, Associate Professor of Medicine at Case Western University and a leading expert in genitourinary tumors. Dr. Barata addresses the topic of kidney cancers, most specifically, renal cell carcinoma (RCC), and clarifies their subtypes and the ways we can treat them. In this episode, we also learn about new therapies, like immunotherapy, and how they are helping prostate cancer patients.

Our guest this week is Dr. Siddhartha Mukherjee, a physician, researcher, and Pulitzer Prize winner. Dr. Mukherjee and Dr. Juneja talk about a new approach to fighting cancer, by analyzing the internal metabolism of the cancer cell so that we can prevent cancer growth by starving it. Dr. Mukherjee shares his learnings on how specific diets - targeting amino acids and other nutrients - in combination with other therapies, can help patients control their cancer.

Our guest this week is Dr. Jay McCracken, Neurosurgical Oncologist at Piedmont Atlanta Brain Tumor Center. Dr. Juneja talks with Dr. McCracken talk about the scary topic that is brain cancer. Can meningiomas be cancerous? Why makes it Glioblastoma so challenging to treat? Dr. McCracken shares some insights on tumor resection and the techniques used to achieve functional preservation. Learn about GammaTile to precisely deliver radiation and how it can dramatically improve the treatment of GBM in comparison with external beam radiation.

Our guest this week is Dr. Ian Walters, CEO of Portage Biotech. Dr. Juneja talks with Dr. Walters to explain how we can potentially educate our own immune system to kill cancer cells and then retain that education to prevent future recurrences. And what if we could create a drug to impact multiple cancers - via existing checkpoint inhibitors or pathways? Watch this episode to find out about the science that is being developed right now.

This episode's guest is Dr. Susan Dent, medical oncologist at Duke Cancer Center and president of the International Cardio-Oncology Society (IC-OS). Dr. Dent and Dr. Juneja talk about the world of cardio-oncology. What is cardio-oncology? How cancer therapies can impact cardiovascular toxicity? And, most importantly, can we prevent it? These are some of the questions that Dr. Dent addresses in this episode and help us understand.

Our guest this week is Dr. John Hood. Dr. Hood, together with Dr. Sanjay, talk about gene mutations on cancer growth and all the advances in next-generation sequencing that are transforming the treatment of cancer as we know it. If you have heard of the terms: NGS, genomic sequencing, or molecular profiling, but are unsure what they mean, how they work, and - especially - how you can benefit from them, this is the episode for you.